Literature DB >> 11037639

[Development and validation of a test for early diagnosis of dementia with differentiation from depression (TFDD)].

R Ihl1, B Grass-Kapanke, P Lahrem, J Brinkmeyer, S Fischer, N Gaab, C Kaupmannsennecke.   

Abstract

Psychometric tests used for the early detection of dementia often are seen as too difficult or too complex. Classical neuropsychologic tests were not developed for this purpose. Sensitivity and specificity to discriminate "healthy" vs. "ill" are low. For measuring both dementive and depressive symptoms, so far no test has been published. The objective of this study was to develop a sensitive and specific test for dementia that is easy to administer and to evaluate. Moreover, it should discriminate dementia from depressive pseudodementia. With respect to former studies, items were selected that recognized patients in the beginning of the disease. Additionally, depressive symptoms were rated. With the items for dementia, 88 patients with dementia of the Alzheimer type, 52 patients with depressive disorder and 37 healthy elderly controls were investigated. In this group of already diagnosed patients, the test reached a sensitivity and specificity of 100 percent (healthy elderly controls vs. patients with Alzheimer's disease: n = 125, U = 0, p < 0.001; patients with depressive disorder vs. patients with Alzheimer's disease: n = 140, U = 0, p < 0.001; healthy elderly controls vs. patients with depressive disorder: n = 89, U = 485.5, p < 0.001). For the dementia items, the inter-rater-reliability was rs = 0.996 (p < 0.001, n = 18), for the depression items it was rs = 0.753 (n = 18, p < 0.001). The test-retest-reliability was rs = 0.868 (p < 0.001, n = 35) for the dementia items and rs = 0.7 (n = 8, p < 0.05) for the depression items. These validation data will make the test useful for practitioners. Its ability to discriminate patients suffering from dementia of the Alzheimer type from healthy controls is comparable to tests consuming more time.

Entities:  

Mesh:

Year:  2000        PMID: 11037639     DOI: 10.1055/s-2000-11799

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  16 in total

1.  [Developmental process of DGPPN quality indicators].

Authors:  I Großimlinghaus; P Falkai; W Gaebel; B Janssen; D Reich-Erkelenz; T Wobrock; J Zielasek
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

2.  [Guideline-based diagnosis of dementia syndrome].

Authors:  W Hofmann
Journal:  Z Gerontol Geriatr       Date:  2012-06       Impact factor: 1.281

Review 3.  [Psychological assessment and psychotherapy for chronic pain in the elderly].

Authors:  P Mattenklodt; C Leonhardt
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

4.  Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.

Authors:  Siegfried Kasper
Journal:  Wien Med Wochenschr       Date:  2015-06-20

5.  Emotion recognition and experience in Huntington disease: a voxel-based morphometry study.

Authors:  Rottraut Ille; Axel Schäfer; Wilfried Scharmüller; Christian Enzinger; Helmuth Schöggl; Hans-Peter Kapfhammer; Anne Schienle
Journal:  J Psychiatry Neurosci       Date:  2011-11       Impact factor: 6.186

6.  [Are mental disorders given due consideration in the adjustment of stage of care according to the German Health Care Act? Assessment of cognitive impairment by medical expert record (MDK) and standardised methods of the research team].

Authors:  A Zintl-Wiegand; B Krumm
Journal:  Nervenarzt       Date:  2003-07       Impact factor: 1.214

Review 7.  [Mild cognitive disorder. Questions of definition, diagnosis, prognosis and therapy].

Authors:  A Kurz; J Diehl; M Riemenschneider; R Perneczky; N Lautenschlager
Journal:  Nervenarzt       Date:  2004-01       Impact factor: 1.214

8.  [Advances in the diagnostics of Alzheimer's disease].

Authors:  U Fiedler; J Wiltfang; N Peters; J Benninghoff
Journal:  Nervenarzt       Date:  2012-05       Impact factor: 1.214

Review 9.  [Hearing and cognition: neurocognitive test batteries in otorhinolaryngology].

Authors:  C Völter; L Götze; U Bruene-Cohrs; S Dazert; J P Thomas
Journal:  HNO       Date:  2020-03       Impact factor: 1.284

10.  Role of disgust proneness in Parkinson's disease: a voxel-based morphometry study.

Authors:  Rottraut Ille; Albert Wabnegger; Petra Schwingenschuh; Petra Katschnig-Winter; Mariella Kögl-Wallner; Karoline Wenzel; Anne Schienle
Journal:  J Int Neuropsychol Soc       Date:  2015-04-24       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.